The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
K Liu, M Zheng, R Lu, J Du, Q Zhao, Z Li, Y Li… - Cancer Cell …, 2020 - Springer
One of the most prominent features of tumor cells is uncontrolled cell proliferation caused by
an abnormal cell cycle, and the abnormal expression of cell cycle-related proteins gives …
an abnormal cell cycle, and the abnormal expression of cell cycle-related proteins gives …
[HTML][HTML] P53 mutations in colorectal cancer-molecular pathogenesis and pharmacological reactivation
Colorectal cancer (CRC) is one of the most common malignancies with high prevalence and
low 5-year survival. CRC is a heterogeneous disease with a complex, genetic and …
low 5-year survival. CRC is a heterogeneous disease with a complex, genetic and …
Efficient RNA drug delivery using red blood cell extracellular vesicles
Most of the current methods for programmable RNA drug therapies are unsuitable for the
clinic due to low uptake efficiency and high cytotoxicity. Extracellular vesicles (EVs) could …
clinic due to low uptake efficiency and high cytotoxicity. Extracellular vesicles (EVs) could …
N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells
Abstract N 6-methyladenosine (m6A) has been identified as the most abundant internal
modification of messenger RNA in eukaryotes. m6A modification is involved in cell fate …
modification of messenger RNA in eukaryotes. m6A modification is involved in cell fate …
[HTML][HTML] Lin28: primal regulator of growth and metabolism in stem cells
In recent years, the highly conserved Lin28 RNA-binding proteins have emerged as factors
that define stemness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and …
that define stemness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and …
MicroRNAs in the p53 network: micromanagement of tumour suppression
H Hermeking - Nature reviews cancer, 2012 - nature.com
In recent years, microRNAs (miRNAs) have been identified as mediators of tumour
suppression and stress responses exerted by the p53 tumour suppressor. p53-regulated …
suppression and stress responses exerted by the p53 tumour suppressor. p53-regulated …
Micro RNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease
J Banzhaf‐Strathmann, E Benito, S May… - The EMBO …, 2014 - embopress.org
Sporadic Alzheimer's disease (AD) is the most prevalent form of dementia, but no clear
disease‐initiating mechanism is known. Aβ deposits and neuronal tangles composed of …
disease‐initiating mechanism is known. Aβ deposits and neuronal tangles composed of …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
A step-by-step microRNA guide to cancer development and metastasis
Background Cancer is one of the leading causes of mortality. The neoplastic transformation
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy
M Prokocimer, A Molchadsky… - Blood, The Journal of the …, 2017 - ashpublications.org
The heterogeneous nature of acute myeloid leukemia (AML) and its poor prognosis
necessitate therapeutic improvement. Current advances in AML research yield important …
necessitate therapeutic improvement. Current advances in AML research yield important …